Press Release
Healthcare News Pharmaceuticals

Glaucoma – Epidemiology Insights (2016-2028)

Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis.

Download the sample report @ https://www.pharmaproff.com/request-sample/1159

 

The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the optic nerve. There are two key categories of glaucoma; open-angle glaucoma (OAG), and narrow angle glaucoma.

Get the detailed analysis @ https://www.pharmaproff.com/report/glaucoma-epidemiology-forecast

 

Glaucoma is mainly associated with old age and its overall prevalence is found to be significantly lower in regions with young population. The epidemiological studies have reported that the global prevalence of glaucoma is approximately 3.5% for people aged 40-80 years.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1159

 

The report covers historical and forecast epidemiology of the disease in the seven major markets including the U.S., EU5 (France, Germany, Italy, Spain, U.K.), and Japan. The report has been compiled by building an understanding of the disease, after reviewing numerous studies conducted by regulatory bodies in various countries.        

 

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: [email protected]

Web: https://www.pharmaproff.com